U.S. Markets closed

Apellis Pharmaceuticals, Inc. (APLS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.46-0.14 (-0.29%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.13
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 349.42
52 Week Low 316.85
50-Day Moving Average 337.12
200-Day Moving Average 332.39

Share Statistics

Avg Vol (3 month) 3593.95k
Avg Vol (10 day) 3733.84k
Shares Outstanding 575.6M
Float 55.26M
% Held by Insiders 121.11%
% Held by Institutions 182.88%
Shares Short (Nov 12, 2020) 49.94M
Short Ratio (Nov 12, 2020) 417.72
Short % of Float (Nov 12, 2020) 420.11%
Short % of Shares Outstanding (Nov 12, 2020) 413.12%
Shares Short (prior month Oct 14, 2020) 410.64M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-69,626.51%

Management Effectiveness

Return on Assets (ttm)-45.54%
Return on Equity (ttm)-437.13%

Income Statement

Revenue (ttm)646k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -449.33M
Net Income Avi to Common (ttm)-536.36M
Diluted EPS (ttm)-8.02
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)728.16M
Total Cash Per Share (mrq)9.61
Total Debt (mrq)372.88M
Total Debt/Equity (mrq)352.31
Current Ratio (mrq)9.86
Book Value Per Share (mrq)1.40

Cash Flow Statement

Operating Cash Flow (ttm)-384.54M
Levered Free Cash Flow (ttm)-215.71M